344 related articles for article (PubMed ID: 27265143)
1. Rebamipide attenuates Helicobacter pylori CagA-induced self-renewal capacity via modulation of β-catenin signaling axis in gastric cancer-initiating cells.
Kang DW; Noh YN; Hwang WC; Choi KY; Min do S
Biochem Pharmacol; 2016 Aug; 113():36-44. PubMed ID: 27265143
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-320a and microRNA-4496 attenuate Helicobacter pylori cytotoxin-associated gene A (CagA)-induced cancer-initiating potential and chemoresistance by targeting β-catenin and ATP-binding cassette, subfamily G, member 2.
Kang DW; Yang ES; Noh YN; Hwang WC; Jo SY; Suh YA; Park WS; Choi KY; Min DS
J Pathol; 2017 Apr; 241(5):614-625. PubMed ID: 28008607
[TBL] [Abstract][Full Text] [Related]
3. Rebamipide abolishes Helicobacter pylori CagA-induced phospholipase D1 expression via inhibition of NFκB and suppresses invasion of gastric cancer cells.
Kang DW; Hwang WC; Park MH; Ko GH; Ha WS; Kim KS; Lee YC; Choi KY; Min DS
Oncogene; 2013 Jul; 32(30):3531-42. PubMed ID: 22890316
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori upregulates Nanog and Oct4 via Wnt/β-catenin signaling pathway to promote cancer stem cell-like properties in human gastric cancer.
Yong X; Tang B; Xiao YF; Xie R; Qin Y; Luo G; Hu CJ; Dong H; Yang SM
Cancer Lett; 2016 May; 374(2):292-303. PubMed ID: 26940070
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori CagA promotes epithelial mesenchymal transition in gastric carcinogenesis via triggering oncogenic YAP pathway.
Li N; Feng Y; Hu Y; He C; Xie C; Ouyang Y; Artim SC; Huang D; Zhu Y; Luo Z; Ge Z; Lu N
J Exp Clin Cancer Res; 2018 Nov; 37(1):280. PubMed ID: 30466467
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori inhibits GKN1 expression via the CagA/p-ERK/AUF1 pathway.
Guo Y; Zhang T; Shi Y; Zhang J; Li M; Lu F; Zhang J; Chen X; Ding S
Helicobacter; 2020 Feb; 25(1):e12665. PubMed ID: 31657090
[TBL] [Abstract][Full Text] [Related]
7. Interaction of MUC1 with beta-catenin modulates the Wnt target gene cyclinD1 in H. pylori-induced gastric cancer.
Udhayakumar G; Jayanthi V; Devaraj N; Devaraj H
Mol Carcinog; 2007 Sep; 46(9):807-17. PubMed ID: 17393422
[TBL] [Abstract][Full Text] [Related]
8. β-Catenin and p120 mediate PPARδ-dependent proliferation induced by Helicobacter pylori in human and rodent epithelia.
Nagy TA; Wroblewski LE; Wang D; Piazuelo MB; Delgado A; Romero-Gallo J; Noto J; Israel DA; Ogden SR; Correa P; Cover TL; Peek RM
Gastroenterology; 2011 Aug; 141(2):553-64. PubMed ID: 21704622
[TBL] [Abstract][Full Text] [Related]
9. CagA mediates epigenetic regulation to attenuate let-7 expression in Helicobacter pylori-related carcinogenesis.
Hayashi Y; Tsujii M; Wang J; Kondo J; Akasaka T; Jin Y; Li W; Nakamura T; Nishida T; Iijima H; Tsuji S; Kawano S; Hayashi N; Takehara T
Gut; 2013 Nov; 62(11):1536-46. PubMed ID: 22936674
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori induces cell migration and invasion through casein kinase 2 in gastric epithelial cells.
Lee YS; Lee DY; Yu DY; Kim S; Lee YC
Helicobacter; 2014 Dec; 19(6):465-75. PubMed ID: 25052887
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori virulence factor CagA promotes tumorigenesis of gastric cancer via multiple signaling pathways.
Yong X; Tang B; Li BS; Xie R; Hu CJ; Luo G; Qin Y; Dong H; Yang SM
Cell Commun Signal; 2015 Jul; 13():30. PubMed ID: 26160167
[TBL] [Abstract][Full Text] [Related]
12. The EPIYA-ABCC motif pattern in CagA of Helicobacter pylori is associated with peptic ulcer and gastric cancer in Mexican population.
Beltrán-Anaya FO; Poblete TM; Román-Román A; Reyes S; de Sampedro J; Peralta-Zaragoza O; Rodríguez MÁ; del Moral-Hernández O; Illades-Aguiar B; Fernández-Tilapa G
BMC Gastroenterol; 2014 Dec; 14():223. PubMed ID: 25539656
[TBL] [Abstract][Full Text] [Related]
13. Regulation of gastric carcinogenesis by Helicobacter pylori virulence factors.
Franco AT; Johnston E; Krishna U; Yamaoka Y; Israel DA; Nagy TA; Wroblewski LE; Piazuelo MB; Correa P; Peek RM
Cancer Res; 2008 Jan; 68(2):379-87. PubMed ID: 18199531
[TBL] [Abstract][Full Text] [Related]
14.
Wan XK; Yuan SL; Wang YC; Tao HX; Jiang W; Guan ZY; Cao C; Liu CJ
World J Gastroenterol; 2016 Dec; 22(48):10566-10574. PubMed ID: 28082808
[TBL] [Abstract][Full Text] [Related]
15. [Advances in CagA protein and CagAmediated pathogenesis of Helicobacter pylori-A review].
Wan X; Liu C
Wei Sheng Wu Xue Bao; 2016 Dec; 56(12):1821-30. PubMed ID: 29741846
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori infection, oxidative DNA damage, gastric carcinogenesis, and reversibility by rebamipide.
Hahm KB; Lee KJ; Kim JH; Cho SW; Chung MH
Dig Dis Sci; 1998 Sep; 43(9 Suppl):72S-77S. PubMed ID: 9753230
[TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of suppression of interleukin-8 production by rebamipide in Helicobacter pylori-stimulated gastric cancer cell lines.
Aihara M; Azuma A; Takizawa H; Tsuchimoto D; Funakoshi Y; Shindo Y; Ohmoto Y; Imagawa K; Kikuchi M; Mukaida N; Matsushima K
Dig Dis Sci; 1998 Sep; 43(9 Suppl):174S-180S. PubMed ID: 9753246
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori CagA and gastric carcinogenesis.
Zheng RN; Li SR; Masahiro A
Asian Pac J Cancer Prev; 2012; 13(12):6305-10. PubMed ID: 23464450
[TBL] [Abstract][Full Text] [Related]
19. CAPZA1 determines the risk of gastric carcinogenesis by inhibiting
Tsugawa H; Mori H; Matsuzaki J; Sato A; Saito Y; Imoto M; Suematsu M; Suzuki H
Autophagy; 2019 Feb; 15(2):242-258. PubMed ID: 30176157
[No Abstract] [Full Text] [Related]
20. Strain-specific suppression of microRNA-320 by carcinogenic Helicobacter pylori promotes expression of the antiapoptotic protein Mcl-1.
Noto JM; Piazuelo MB; Chaturvedi R; Bartel CA; Thatcher EJ; Delgado A; Romero-Gallo J; Wilson KT; Correa P; Patton JG; Peek RM
Am J Physiol Gastrointest Liver Physiol; 2013 Dec; 305(11):G786-96. PubMed ID: 24136787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
